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Time to rename exacerbations of COPD: implementing the term lung attack in the Netherlands  
 
To the editor:  
Bafadhel et al. make a compelling case for renaming the term exacerbation in COPD.1 The most 
important reason is that less than 2% of patients with COPD know what the term exacerbation means, 
and hence do not feel the urgency of the event. Many physicians too lack this sense of urgency, and 
for instance are ignorant that 2-year mortality after a hospitalization for COPD exacerbation is higher 
than that for a heart attack.2 
We would like to share the experience we have in the Netherlands with renaming exacerbations. A 
nation-wide Patient Empowerment (2012) project focused on improving self-management skills of 
patients with COPD, particularly exacerbation management. The broadly constituted working group 
represented pulmonary physicians and specialized nurses, family physicians, and patients (Lung 
Foundation Netherlands). In order to better understand the poor sense of urgency, and what to do 
about it, among others a national survey was performed. Knowledge of the term was indeed low. Next, 
patients were offered several alternatives from which they preferred “lung attack”. Any term can be 
debated, but all project members agreed that renaming exacerbation to lung attack would help to 
emphasize the urgency, especially since it runs parallel with existing terminology such as heart attack.  
Whatever new term introduced for any disease, it needs broad support for implementation and 
framing. This is what happened in the Netherlands. First, a COPD “lung attack” action plan was made 
available on a national scale (Lung Foundation Netherlands). Second, the strong position of the 
Netherlands Lung Alliance allowed, as part of a National Action programme,3 the successful piloting of 
an integrated care pathway for COPD, aimed specifically at reducing hospitalization days for “lung 
attacks”.4 Third, a specific national guideline ‘Diagnosis and treatment of a COPD lung attack in 
hospital’ was developed, again adopting the term lung attack. Fourth, the recent update of the COPD 
guideline from the general practitioners followed suit. 
To our opinion, lung attack sounds less alarmistic than crisis which might be the case in hospital, but 
in the majority of cases is probably overstated.  
Regardless of the term chosen, a joint effort between patients and the respiratory health community is 
needed to rename exacerbations and effectively implement the new term. Our experience on a small 
but national scale has proven successful. We applaud the authors’ appeal to rename exacerbations, 
and share their belief that it will contribute to the health of COPD patients. 
Sebastiaan Holverda, Lung Foundation Netherlands 
Michael R. Rutgers, Lung Foundation Netherlands 
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